Medical Therapy. Efficacy or Lack of Efficacy

Intravenous prostacyclins for right ventricular failure following left ventricular assist device in paediatric heart failure

Laura J. Radel, Mehreen Iqbal, Megan GriffithsUniversity of Texas Southwestern.United States Cardiology in the YoungCardiol Young 2023; DOI: 10.1017/S1047951123001725 AbstractRight ventricular failure after placement of left ventricular assist device in paediatric heart failure is associated with increased mortality. We report successful use of intravenous prostacyclin for right ventricular support and pulmonary hypertension after initiation of left […]

Intravenous prostacyclins for right ventricular failure following left ventricular assist device in paediatric heart failure Read More »

Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension

Jefferson Antonio Buendia, Diana Guerrero Patino, Erika Fernanda LindarteUniversity of Antioquia. University of Oxford. Columbia and United Kingdom Expert Review of Pharmacoeconomic and Outcomes ResearchExpert Rev Pharmacoecon Outcomes Res 2023; DOI: 10.1080/14737167.2023.2233698 AbstractIntroduction: Despite the increasing evidence supporting the efficacy of ambrisentan and bosentan in improving functional classes among pediatric patients with pulmonary arterial hypertension (PAH), there

Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension Read More »

Retrospective on global pulmonary hypertension clinical trials: 1999-2021

Lu Zheng, Jun Tan, Yi Yan, Shang Wang, Ping Yuan, Cheng Wu, Yin-Tao Zhao, Hai-Bo Yang, Francesco Nappi, Adriano R. Tonelli, Lan Wang, Qing-Hua Hu, Rong JiangFirst Affiliated Hospital of Zhengzhou University. Yeda Hospital of Yantai. Shanghai Children’s Medical Center and National Children’s Medical Center. Shanghai Pulmonary Hospital and Tongji University. Naval Medical University. Centre

Retrospective on global pulmonary hypertension clinical trials: 1999-2021 Read More »

Factors leading to supranormal cardiac index in pediatric pulmonary hypertension patients treated with parenteral prostanoid therapy

Kimberley G. Miles Paul J. Critser, Patrick D. Evers, Michelle Cash, Melissa Magness, Elizabeth Geers Meredith O’Neil, Zhiqian Gao, Nicholas J. Ollberding, Russel HirschCincinnati Children’s Hospital Medical Center and Cincinnati College of Medicine. Oregon Health and Sciences University. United States Pulmonary CirculationPulm Circ 2023;DOI: 10.1002/pul2.12264 AbstractParenteral prostanoid therapy (PPT) can result in supranormal cardiac index (SCI;

Factors leading to supranormal cardiac index in pediatric pulmonary hypertension patients treated with parenteral prostanoid therapy Read More »

Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia

Maria V. Fraga, Kevin C. Dysart, Jason Z. Stroller, Matthew Huber, Anysia Fedec, Laura Mercer-Rosa, Haresh KirpalaniThe Children’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine. Nemours Children’s Health and duPont Hospital for Children. McMaster University.United States and Canada NeonatologyNeonatology 2023; DOI: 10.1159/000531586 AbstractObjectives: Inhaled nitric oxide (iNO) is an effective pulmonary vasodilator. However,

Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia Read More »

Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction

Michael G. Katz, Yoav Hadas, Adam Vincek, Lina Freage‑Kahn, Nataly Shtraizent, Jeko M. Madjarov, Peter Pastuszko, Efrat Eliyahu Icahn School of Medicine at Mount Sinai. SeneX Therapeutics Inc. Atrium Health Sanger Heart and Vascular Institute. Wake Forest School of Medicine. United States Respiratory ResearchRespir Res 2023; 24DOI: 10.1186/s12931-023-02487-2 AbstractBackground: Up-regulation of ceramides in pulmonary hypertension (PH), contributing to

Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction Read More »

Practices and Outcomes from a Prospective, Multicenter Registry for Preterm Newborns with Pulmonary Hypertension

Nicolle Fernandez Dyess, Claire Palmer, Roger F. Soll, Reese H. Clark, Steven H. Abman, John P. Kinsella and the Preterm Newborn Pulmonary Hypertension Registry Study Group with Multiple Collaborating InvestigatorsUniversity of Colorado School of Medicine. University of Vermont. Pediatrix Center for Research. Multiple Collaborating Institutions.United States Journal of PediatricsJ Pediatr 2023; DOI: 10.1016/j.jpeds.2023.113614 AbstractObjective: To describe current

Practices and Outcomes from a Prospective, Multicenter Registry for Preterm Newborns with Pulmonary Hypertension Read More »

Pulmonary Vasodilator Therapy in Pediatric Patients on Ventricular Assist Device Support: A Single-Center Experience and Proposal for Use

Jennifer E. Schramm, John C. Dykes, Rachel K. Hopper, Jeffrey A. Feinstein, David N. Rosenthal, Rebecca J. KamenyJohns Hopkins University School of Medicine. Stanford University School of Medicine.United States American Society for Artificial Internal Organs JournalASAIO J 2023; DOI: 10.1097/MAT.0000000000002023 AbstractPediatric precapillary pulmonary hypertension can develop in response to systemic atrial hypertension. Systemic atrial decompression following

Pulmonary Vasodilator Therapy in Pediatric Patients on Ventricular Assist Device Support: A Single-Center Experience and Proposal for Use Read More »

Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension

Faith Zhu, Daniel Ibarra Rios, Sebastien Joye, Michelle Baczynski, Danielle Rios, Regan E. Giesinger, Patrick J. McNamara, Amish JainMount Sinai Hospital and University of Toronto. Hospital Infantil de México Federico Gómez. Lausanne University Hospital. University of Iowa.Canada, Mexico, Switzerland and United States Journal of PerinatologyJ Perinatol 2023DOI: 10.1038/s41372-023-01742-0 AbstractObjective: Using targeted neonatal echocardiography (TNE) to examine cardiopulmonary

Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension Read More »

Association between immediate oxygenation response and survival in preterm infants receiving rescue inhaled nitric oxide therapy for hypoxemia from pulmonary hypertension: A systematic review and meta-analysis

Michelle Baczynski, Bonny Jasani, Charmaine De Castro, Carlo Dani, Nimish V. Subhedar, Praveen Chandrasekharan, Satvan Lakshminrusimha, Patrick J. McNamara, Adrianne R. Bishchoff, Amish JainMount Sinai Hospital. Hospital for Sick Children. Careggi University Hospital of Florence and University of Florence. Liverpool Women’s Hospital. University at Buffalo. UC Davis Children’s Hospital. University of Iowa. Canada, Italy, United

Association between immediate oxygenation response and survival in preterm infants receiving rescue inhaled nitric oxide therapy for hypoxemia from pulmonary hypertension: A systematic review and meta-analysis Read More »

Scroll to Top